Using blood tests to detect and monitor colorectal cancer

Is this trial a fit for you?

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This study evaluates the effectiveness of circulating tumor DNA (ctDNA) as a liquid biopsy for diagnosing and monitoring colorectal cancer. It aims to determine if ctDNA markers can identify colorectal cancer patients among those scheduled for colonoscopy and how these markers correlate with cancer subtype and progression. Participants will provide blood samples and complete a questionnaire to aid in the analysis. The study focuses on the clinical utility of ctDNA in improving patient outcomes.

Why it matters

Who can join: the full rules

Inclusion Criteria:

* Patient ≥ 18 years old summoned for colonoscopy
* Patient able to understand and sign written informed consent

Exclusion Criteria:

* Patient \< 18 years old
* Patient unable to understand or give written informed consent
* Patient unlikely to comply with the protocol (e.g. uncooperative attitude, inability to return for subsequent visits) and/or otherwise considered by the investigator as unlikely to complete the study

Where it's running

• Nord-Trøndelag Hospital Trust
  Levanger, Norway Recruiting

Study contacts

• Study coordinator: Eivor A Laugsand, MD, PhD
• Email: eivor.a.laugsand@ntnu.no
• Phone: +47 74075180

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

• Colorectal Cancer Screening: a Blood Test for a Better Path to Colonoscopy

  A blood-based biomarker test using five ofCS markers is being tested to better sort people who need a colonoscopy from those who don’t.

  Recruiting at 2 sites Nordsjaellands Hospital · Hillerød and 1 other locations · NCT07237984

• Non-invasive urine and stool tests for early colorectal cancer diagnosis

  This study is testing if special urine and stool tests can help find colorectal cancer early in patients who have already had a positive blood test.

  Recruiting at 2 sites Institut Investigacio Sanitaria Pere Virgili · Reus, Tarragona and 1 other locations · NCT06452745

• Using a microwave device to improve colonoscopy for detecting polyps

  This study is testing a new microwave device during colonoscopies to see if it can help doctors find more polyps that might be missed with regular methods.

  Recruiting MiWEndo Solutions S.L. · Barcelona · NCT05988645

• Comparing colonoscopy and stool testing for older adults with colon polyps

  This study is testing whether a simple stool test can be just as effective as colonoscopy for monitoring older adults with a history of colon polyps.

  Recruiting at 22 sites Dartmouth-Hitchcock Medical Center · Birmingham, Alabama and 23 other locations · NCT05612347

• New oral synbiotic formula to reduce colorectal adenoma recurrence

  This study is testing a new oral formula made of probiotics and prebiotics to see if it can help prevent the return of certain growths in the colon after they've been removed.

  Recruiting Chinese University of Hong Kong · Hohhot, Inner Mongolia and 1 other locations · NCT05592886

• Knife-assisted full-thickness resection for rectal lesions in a multicenter setting

  A multicenter study tests knife-assisted full-thickness resection (kFTR) to remove rectal lesions in adults and see how well it works and how safe it is.

  Recruiting University Hospital, Ghent · Ghent · NCT07923682

How to take part

1. Review the eligibility criteria above with your treating physician.
2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.